Registry on Percutaneous Electrochemotherapy

NCT05267080 · tracked via the Priya Life Science Germany tracker

Sponsor

Cardiovascular and Interventional Radiological Society of Europe

Phase

Observational

Started

2023-01-25

Last updated

2026-02-06

Condition(s) studied

Primary Liver CancerSecondary Liver Cancer

Investigational drug(s) / intervention(s)

CLINIPORATOR

CLINIPORATOR: The CLINIPORATOR is used to perform percutaneous electrochemotherapy on liver tumours.

Study summary

The Registry on Percutaneous ElectroChemoTherapy (RESPECT) is a post-market, prospective, non-randomized, observational study aiming at evaluating the effectiveness of percutaneous electrochemotherapy (ECT) for the treatment of liver cancer.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * 18 years or older * Primary or secondary liver cancer * Referral to local ablative treatment by multidisciplinary tumour board and decision to treat with pECT by interventional radiologist in charge * Planned treatment with pECT using the CLINIPORATOR * Signed informed consent form Exclusion Criteria: Pregnancy

Primary outcome measure(s)

Local Tumour Control — 12 months
Based on the tumour status according to mRECIST assessment

Trial sites (15)

Facility	City	Region
Centre Hospitalier Universitaire de Montpellier	Montpellier	France
Hôpital Européen Georges-Pompidou	Paris	France
Institut Gustave Roussy	Paris	France
WEGE Klinik	Bonn	Germany
Städtisches Klinikum Braunschweig	Braunschweig	Germany
Universitätsklinikum Halle	Halle	Germany
Helios Park-Klinikum	Leipzig	Germany
University Hospital Regensburg	Regensburg	Germany
University of Szeged	Szeged	Hungary
Istituto Europeo di Oncologia	Milan	Italy
Fondazione Policlinico Universitario Campus Bio-Medico	Rome	Italy
Policlinico Universitario A. Gemelli	Rome	Italy
Vilnius University Hospital Santariškių Klinikos	Vilnius	Lithuania
Hospital Universitario y Politécnico La Fe	Valencia	Spain
Leeds Teaching Hospitals NHS Trust	Leeds	United Kingdom

More Cardiovascular and Interventional Radiological Society of Europe trials in Germany

Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study Active, not recruiting

Other trials for the same condition

The Dragon PLC Trial (DRAGON-PLC) Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05267080 on ClinicalTrials.gov ↗ ← All trials in Germany